Dexmedetomidine vs Midazolam for CT Sedation in ICU patients: a Randomized Controlled Trial

xmedetomidine vs Midazolam for CT Sedation in ICU patients: a Randomized Controlled Clinical Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002766

Enrollment

Unknown

Registered

2012-12-07

Start date

2012-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically disease

Interventions

Dexmedetomidine Hydrochloride:Dexmedetomidine Hydrochloride

Midazolam:Midazolam

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) patients in the ICU; (2) intrahospital transport to CT diagnostic tests; (3) agitation (RASS >=2) or artificial airway.

Exclusion criteria

Exclusion criteria: (1) age =5.5, pH <7.2; (11) patients who need emergency treatment or rescue; (12) consent of the patients or their family members can not be obtained; (13) patients who were included in the study once or being in other studies which may affect the study; (14) serious liver and kidney dysfunction, such as Childs-Pugh grade C; (15) the pre-transshipped patients on a trial basis with simple respirator or transporter ventilator support, SaO2 <90% or PaO2 <60mmHg; (16) RASS score <-3; (17) the patients can not be ruled out sedative and analgesic drug accumulation after stopping sedative or analgesic 6 hours in spite of fulfilling the inclusion criteria.

Design outcomes

Primary

Measure	Time frame
percentage of target sedation time;	—

Countries

China

Contacts

Public ContactKaijiang Yu

drkaijiang@sohu.com+86 13303608899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026